MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 5 | 0.0 |
Animals | 22 | 0.0 |
Base Sequence | 12 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Hela Cells | 8 | 0.0 |
Humans | 52 | 0.0 |
Mice | 16 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Promoter Regions (Genetics)/*immunology | 3 | 6.0 |
Protein Binding/genetics/immunology | 2 | 2.0 |
Research Support, Non-U.S. Gov't | 41 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
Adult | 14 | 0.0 |
Cross-Sectional Studies | 4 | 0.0 |
Female | 21 | 0.0 |
Infant | 10 | 0.0 |
Infant, Newborn | 6 | 0.0 |
Male | 16 | 0.0 |
Nigeria | 3 | 4.0 |
Immunoglobulin Variable Region/*genetics | 2 | 1.0 |
Jurkat Cells | 3 | 0.0 |
B-Lymphocytes/*physiology | 5 | 3.0 |
*Receptors, Cell Surface | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Cell Line | 6 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
*Genes, Immunoglobulin | 3 | 1.0 |
*Recombination, Genetic | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 12 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
Transcription, Genetic | 7 | 0.0 |
Transfection | 4 | 0.0 |
VDJ Recombinases | 2 | 3.0 |
Adolescent | 7 | 0.0 |
Educational Status | 2 | 3.0 |
*Health Knowledge, Attitudes, Practice | 3 | 10.0 |
Pregnancy | 3 | 0.0 |
Questionnaires | 2 | 0.0 |
Cell Differentiation | 5 | 0.0 |
Cell Survival | 2 | 0.0 |
*Breast Feeding | 7 | 10.0 |
*Child Development | 2 | 6.0 |
Comparative Study | 7 | 0.0 |
Honduras | 8 | 80.0 |
Infant Food | 4 | 17.0 |
Infant Nutrition | 3 | 14.0 |
Time Factors | 7 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Milk, Human | 2 | 18.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Genes, Immunoglobulin | 2 | 1.0 |
Immunoglobulin Variable Region/genetics | 2 | 1.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Trans-Activators/*metabolism | 3 | 0.0 |
Cell Lineage | 4 | 0.0 |
Dimerization | 2 | 0.0 |
*Helix-Loop-Helix Motifs | 2 | 2.0 |
Membrane Glycoproteins/*genetics | 2 | 0.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
Protein Binding | 2 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Phenotype | 2 | 0.0 |
DNA/genetics/metabolism | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Mutation | 3 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
*Transcription Factors | 3 | 0.0 |
Prospective Studies | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Hematopoietic Stem Cells/*physiology | 4 | 3.0 |
Age Factors | 4 | 0.0 |
Birth Weight | 2 | 1.0 |
Energy Intake | 2 | 1.0 |
*Infant Food | 2 | 5.0 |
Antigens, CD/*genetics | 2 | 0.0 |
Binding Sites | 6 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 3 | 0.0 |
Trans-Activators/genetics/*metabolism | 3 | 0.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
DNA-Binding Proteins/*genetics/*metabolism | 2 | 1.0 |
Membrane Glycoproteins/genetics | 2 | 1.0 |
Trans-Activators/*genetics | 2 | 0.0 |
Multivariate Analysis | 3 | 0.0 |
Regression Analysis | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Aged | 4 | 0.0 |
Follow-Up Studies | 5 | 0.0 |
Middle Aged | 5 | 0.0 |
Chi-Square Distribution | 2 | 0.0 |
Logistic Models | 3 | 0.0 |
Socioeconomic Factors | 2 | 1.0 |
B-Lymphocytes/*cytology | 3 | 4.0 |
Chromosome Mapping | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Helix-Loop-Helix Motifs | 2 | 0.0 |
Receptors, Antigen, B-Cell/*genetics | 2 | 18.0 |
Analysis of Variance | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
*Cell Differentiation | 2 | 0.0 |
*Cell Lineage | 2 | 8.0 |
Data Collection | 2 | 2.0 |
Longitudinal Studies | 2 | 0.0 |
Breast Feeding/*statistics & numerical data | 3 | 100.0 |
Prevalence | 2 | 0.0 |
Alprostadil/*pharmacology/therapeutic use | 2 | 100.0 |
Trimethaphan/*pharmacology/therapeutic use | 2 | 100.0 |
English Abstract | 3 | 0.0 |
